copper 2-benzo[f]benzimidazol-1-id-2-ylphenolate
|
|
Descriptors Computed from Structure
Canonical SMILES:
C1=CC=C2C=C3C(=CC2=C1)[N-]C(=N3)C4=CC=CC=C4[O-].[Cu+2]
Isomeric SMILES
C1=CC=C2C=C3C(=CC2=C1)[N-]C(=N3)C4=CC=CC=C4[O-].[Cu+2]
InChI
InChI=1S/C17H11N2O.Cu/c20-16-8-4-3-7-13(16)17-18-14-9-11-5-1-2-6-12(11)10-15(14)19-17;/h1-10H,(H-,18,19,20);/q-1;+2/p-1
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- copper 2-benzo[f]benzimidazol-1-id-2-yl-5-methoxy-phenolate
- 6-(1,3-dihydrobenzo[f]benzimidazol-2-ylidene)-3-methoxy-cyclohexa-2,4-dien-1-one
- 2-bromanyl-1,3,10-tris(oxidanyl)-5-[(2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-trienyl]-11H-benzo[b][1,4]benzodiazepin-6-one
- 5-(2,4,6-trimethylphenyl)carbonylnaphthalene-1,4-dione
- [5,8-bis(oxidanyl)naphthalen-1-yl]-(2,4,6-trimethylphenyl)methanone
- 2,7,8-tris(oxidanyl)naphthalene-1-carbaldehyde
- (3R,5R,7R,10S,13R)-3-[3-[2-(3-azanylpropylamino)ethylamino]propylamino]-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol
- (3S,5R,7S,10S,13R)-3-[4-(4-azanylbutylamino)butylamino]-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol
- N-[(5aR,6aS,7S,9Z,10aS)-9-[azanyl(oxidanyl)methylidene]-4,7-bis(dimethylamino)-1,10a,12-tris(oxidanyl)-8,10,11-tris(oxidanylidene)-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]piperidine-4-carboxamide hydrochloride
- (3S,7R,10S,13R)-3-[3-[4-[3-[(3-methoxy-4-oxidanyl-phenyl)methylamino]propylamino]butylamino]propylamino]-10,13-dimethyl-17-[(2S)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-7-ol
